BridgeMD
New treatment option for Juvenile Idiopathic Arthritis
Official title Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIA
ClinicalTrials.gov ID: NCT05310799
What this study is testing
- What it's testing
- The PERSON-JIA Trial is a cluster-randomized trial testing the use of Shared Decision Making (SDM) with families for treatment of children with arthritis. The intervention is a discussion between physicians and families at the time of diagnosis that uses computer-generated personalized outcome reports generated by previously developed prediction algorithms.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 18
You may be able to join if
- Physicians (Inclusion):
- Licensed to practice pediatric rheumatology in Canada;
- Providing care for children with JIA at least once a month;
- Consent to be assigned by chance and to implement the SDM intervention for the duration of the trial, if assigned by chance to the intervention arm;
- Commit to propose enrollment in the Registry to all their newly diagnosed patients with JIA during the trial. Physicians (Exclusion):
See the full eligibility criteria
- Physicians (Inclusion):
- Licensed to practice pediatric rheumatology in Canada;
- Providing care for children with JIA at least once a month;
- Consent to be assigned by chance and to implement the SDM intervention for the duration of the trial, if assigned by chance to the intervention arm;
- Commit to propose enrollment in the Registry to all their newly diagnosed patients with JIA during the trial. Physicians (Exclusion):
- Fellows-in-training;
- Physicians planning to retire within 2 years. Patient (Inclusion):
- Consent to include their information in the CAPRI JIA Registry;
- Consent to the PERSON-JIA trial and answering additional questionnaires to assess decision making;
- Allow recording of their medical encounter (if selected at random);
- JIA fulfilling International League of Associations for Rheumatology (ILAR) criteria;
- Newly diagnosed (within the last month);
- Diagnosed by a pediatric rheumatologist participating in the PERSON-JIA study;
- Not yet receiving treatment, or received only Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) or joint injections; Patient (Exclusion):
- Systemic arthritis category of JIA (it requires a different treatment approach);
- Family is unable to complete study forms in English or French;
- Patients who have already started systemic corticosteroid or any Disease Modifying Anti-Rheumatic Drug (DMARD).
The study team makes the final eligibility decision.
Where it's taking place
- Vancouver, British Columbia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vancouver, British Columbia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.